Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2)
Meng Chai(Capital Medical University), Ping Qiao, Guoyan Zhao(Washington University in St. Louis), Lei Qian, Dongmei Shi(Weifang University), Haoyu Li(Central South University), Yuyang Liu(Capital Medical University), Pei An(Peking University), Yujie Zhou(Wuhan University), Yong‐Ming He(Soochow University), Xuebin Han(Shanxi Cardiovascular Hospital), Zhao Wang(Hainan University), Wei Han, Huan Deng(Nanchang University), Shuling Yan, Qingyang Ma, Xueping Ma(Nanjing General Hospital of Nanjing Military Command)
Cited by 50
Related Papers
Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china
|Annals of Neurology|2011|507
Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome
|Cell Host & Microbe|2016|441